Are you Dr. Iqbal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
1 Maloney
Philadelphia, PA 19104Phone+1 215-662-2300
Summary
- Dr. Nayyar Iqbal, MD is an endocrinologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Illinois. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.
Education & Training
- Indiana University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1997
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1992 - 1995
- Aga Khan Medical CollegeClass of 1990
Certifications & Licensure
- PA State Medical License 1997 - 2024
- IL State Medical License 1992 - 1999
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes Start of enrollment: 2004 Sep 01
- Chromium Picolinate for the Treatment of Metabolic Syndrome Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 3 citationsPerspectives in weight control in diabetes - SGLT2 inhibitors and GLP-1-glucagon dual agonism.Nayyar Iqbal, Philip Ambery, Jennifer Logue, Ashwini Mallappa, C David Sjöström
Diabetes Research and Clinical Practice. 2023-05-01 - 2 citationsJoint longitudinal and time-to-event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular diseas...Abderrahim Oulhaj, Faisal Aziz, Abubaker Suliman, Nayyar Iqbal, Ruth L Coleman
Diabetes, Obesity & Metabolism. 2023-05-01 - 2 citationsLong-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension t...Juan P. Frias, Jill Maaske, Lisa J. Suchower, Lars Johansson, Paul D. Hockings
Diabetes, Obesity & Metabolism. 2021-09-28